BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34091824)

  • 1. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.
    Heudel PE; Fervers B; Durand T; Chabaud S; Michallet AS; Gomez F; Rivoire M; Bachelot T; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Chvetzoff G; Pérol D; Blay JY
    Int J Clin Oncol; 2021 Oct; 26(10):1793-1804. PubMed ID: 34091824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980-2014: A nationwide study.
    Schmidt Jensen J; Grønhøj C; Ruud Kjær EK; Charabi BW; von Buchwald C; Hjuler T
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109648. PubMed ID: 31472358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of second primary cancers in North Portugal-a population-based study.
    Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
    J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis.
    Rubió-Casadevall J; Galceran J; Ameijide A; Puigdemont M; Llauradó L; Marruecos J; Izquierdo A; Carulla M; Borràs JL; Marcos-Gragera R; Gumà J
    Clin Transl Oncol; 2021 Apr; 23(4):788-798. PubMed ID: 32815088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.
    Morais S; Antunes L; Bento MJ; Lunet N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):85-91. PubMed ID: 28843176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
    Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
    Heudel P; Chabaud S; Perol D; Flechon A; Fayette J; Combemale P; Tredan O; Desseigne F; de la Fouchardiere C; Boyle H; Perol M; Bachelot T; Cassier P; Avrillon V; Terret C; Michallet AS; Neidhardt-Berard EM; Nicolas-Virelizier E; Dufresne A; Belhabri A; Brahmi M; Lebras L; Nicolini F; Sarabi M; Rey P; Bonneville-Levard A; Rochefort P; Provensal AM; Eberst L; Assaad S; Swalduz A; Saintigny P; Toussaint P; Guillermin Y; Castets M; Coutzac C; Meeus P; Dupré A; Durand T; Crochet H; Fervers B; Gomez F; Rivoire M; Gregoire V; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Lasset C; Chvetzoff G; Mehlen P; Beaupère S; Zrounba P; Ray-Coquard I; Blay JY
    ESMO Open; 2021 Feb; 6(1):100044. PubMed ID: 33516148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
    Guérin J; Nahid A; Tassy L; Deloger M; Bocquet F; Thézenas S; Desandes E; Le Deley MC; Durando X; Jaffré A; Es-Saad I; Crochet H; Le Morvan M; Lion F; Raimbourg J; Khay O; Craynest F; Giro A; Laizet Y; Bertaut A; Joly F; Livartowski A; Heudel P
    Int J Environ Res Public Health; 2024 Feb; 21(2):. PubMed ID: 38397680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.
    Neumann F; Jégu J; Mougin C; Prétet JL; Guizard AV; Lapôtre-Ledoux B; Bara S; Bouvier V; Colonna M; Troussard X; Trétarre B; Grosclaude P; Velten M; Woronoff AS
    Prev Med; 2016 Sep; 90():52-8. PubMed ID: 27370167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancer incidence and risk factors in patients with salivary gland cancers.
    Kwon M; Lee JI; Roh JL; Cho KJ; Choe J; Choi SH; Nam SY; Kim SY
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):118-23. PubMed ID: 24370632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide rates among patients with first and second primary cancer.
    Jiang Y; Wang Y; Cheng X; Zhou Z; Wang J; Yu H; Yao G; Lu Z; Chen X; Yan S; Zhao F
    Epidemiol Psychiatr Sci; 2023 Sep; 32():e57. PubMed ID: 37711033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study.
    Ruan Z; Zhang Y; Li Z; Jiang J; Luo W; Quan Q; Xu Z; Lei J; Peng R
    Clin Exp Med; 2023 Dec; 23(8):5051-5062. PubMed ID: 37555912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
    Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
    Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
    Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
    Cancer Med; 2020 Nov; 9(21):8258-8265. PubMed ID: 32960498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors.
    Moitry M; Velten M; Trétarre B; Bara S; Daubisse-Marliac L; Lapôtre-Ledoux B; Troussard X; Molinié F; Ligier K; Woronoff AS; Bouvier V; Colonna M; Klein D; Guizard AV; Jégu J
    Cancer Epidemiol; 2017 Apr; 47():35-41. PubMed ID: 28113110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
    Chuang SC; Scelo G; Tonita JM; Tamaro S; Jonasson JG; Kliewer EV; Hemminki K; Weiderpass E; Pukkala E; Tracey E; Friis S; Pompe-Kirn V; Brewster DH; Martos C; Chia KS; Boffetta P; Brennan P; Hashibe M
    Int J Cancer; 2008 Nov; 123(10):2390-6. PubMed ID: 18729183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.